SecBot SecBot
144 ·Filed Apr 20, 2026

DYN

Dyne Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed7mo ago SEC0001628280-26-026024
Actionable Insight ▼ Bearish

Monitor for actual sales execution in the coming days, as coordinated Form 144 filings from major early investors may signal reduced confidence or capital reallocation. Given the $2.9M scale and recent insider selling trend, consider increased downside risk ahead of potential supply pressure.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$19.21
T+0 close · Apr 20, 2026 · via day close
Latest settled
+18.27%
T+60 · $22.72
Vs SPY
+11.37%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $19.21entry
  2. T+1 · 7mo ago +2.39%α +1.38% · $19.67
  3. T+5 · 7mo ago −5.47%α −6.55% · $18.16
  4. T+20 · 6mo ago −13.90%α −18.81% · $16.54
  5. T+60 · 4mo ago +18.27%α +11.37% · $22.72
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two affiliated venture funds, Atlas Venture Fund XI and Atlas Venture Opportunity Fund I, filed Form 144 notices to sell a combined 198,926 shares of Dyne Therapeutics stock, representing an intent to sell approximately $2.9 million worth of shares. The sales are planned under Rule 144 following private placement acquisitions in 2020.

Key Facts

  • Atlas Venture Fund XI filed to sell 142,571 shares, valued at approximately $2.05 million based on recent market price
  • Atlas Venture Opportunity Fund I filed to sell 56,355 shares, valued at approximately $815,000
  • Total proposed sale: 198,926 shares worth ~$2.87 million
  • Shares were acquired in private placements in July and August 2020
  • Sales are being conducted through Merrill Lynch in San Francisco
  • Both filings were submitted on the same day (April 20, 2026), indicating coordinated action

Financial Impact

$2.87 million in planned insider sales from two affiliated venture funds

insider ownershipshare dilution riskmarket sentiment

Risk Factors

  • Potential downward pressure on stock price if sales are executed rapidly
  • Signal of waning confidence from early institutional investors
  • Increased share supply in a potentially illiquid biotech stock

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (DYN), Batch item 10001628280-26-026024
Document: 0001628280-26-026024-index.html0001628280-26-026023
Document: 0001628280-26-026024.txt0001628280-26-026024
144 Filing (DYN), Batch item 40001628280-26-026023
Document: 0001628280-26-026023-index.html0001628280-26-026024
Document: 0001628280-26-026023.txt0001628280-26-026024

Track record

54 reports on DYN

Performance horizon

11 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (9h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026